KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Return on Capital Employed (2020 - 2025)

Historic Return on Capital Employed for Royalty Pharma (RPRX) over the last 6 years, with Q4 2025 value amounting to 0.08%.

  • Royalty Pharma's Return on Capital Employed rose 100.0% to 0.08% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.08%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.09% for FY2025, which is 0.0% changed from last year.
  • As of Q4 2025, Royalty Pharma's Return on Capital Employed stood at 0.08%, which was up 100.0% from 0.08% recorded in Q3 2025.
  • Royalty Pharma's 5-year Return on Capital Employed high stood at 0.11% for Q1 2025, and its period low was 0.02% during Q4 2022.
  • In the last 5 years, Royalty Pharma's Return on Capital Employed had a median value of 0.08% in 2021 and averaged 0.07%.
  • As far as peak fluctuations go, Royalty Pharma's Return on Capital Employed tumbled by -700bps in 2021, and later surged by 700bps in 2023.
  • Quarter analysis of 5 years shows Royalty Pharma's Return on Capital Employed stood at 0.08% in 2021, then crashed by -77bps to 0.02% in 2022, then soared by 390bps to 0.09% in 2023, then dropped by -18bps to 0.08% in 2024, then rose by 8bps to 0.08% in 2025.
  • Its Return on Capital Employed stands at 0.08% for Q4 2025, versus 0.08% for Q3 2025 and 0.11% for Q2 2025.